The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Evolent Health Inc shares valued at $38,199 were purchased by Springstubb Brendan B on Nov 18 ’25. At $3.82 per share, Springstubb Brendan B acquired 10,000 shares. The insider’s holdings grew to 58,821 shares worth approximately $0.21 million following the completion of this transaction.
Also, Holder Diane purchased 2,735 shares, netting a total of over 25,518 in proceeds. Following the buying of shares at $9.33 each, the insider now holds 70,584 shares.
Before that, McCarthy Daniel Joseph had added 11,040 shares to its account. In a trade valued at $99,470, the PRESIDENT bought Evolent Health Inc shares for $9.01 each. Upon closing the transaction, the insider’s holdings increased to 11,040 shares, worth approximately $1.38 million.
As published in a research note from Stephens on November 13, 2025, Evolent Health Inc [EVH] has been rated up from an Equal-weight to an Overweight and the price target has been revised to $7. Analysts at BMO Capital Markets started covering the stock with ‘”an Outperform”‘ outlook in a report released in mid November. As of January 10, 2025, Needham has initiated its “Buy” rating for EVH. Earlier on December 03, 2024, BTIG Research resumed its rating. Their recommendation was “a Buy” for EVH stock.
Analyzing EVH Stock Performance
On last trading session, Evolent Health Inc [NYSE: EVH] plunged -11.50% to $3.54. The stock’s lowest price that day was $3.5, but it reached a high of $3.965 in the same session. During the last five days, there has been a drop of approximately -20.45%. Over the course of the year, Evolent Health Inc shares have dropped approximately -71.41%. Shares of the company reached a 52-week high of $12.98 on 01/10/25 and a 52-week low of $3.49 on 11/19/25.
Support And Resistance Levels for Evolent Health Inc (EVH)
According to the 24-hour chart, there is a support level at 3.36, which, if violated, would cause prices to drop to 3.17. In the upper region, resistance lies at 3.86. The next price resistance is at 4.18. RSI (Relative Strength Index) is 16.95 on the 14-day chart, showing oversold technical sentiment.
Is Evolent Health Inc subject to short interest?
Stocks of Evolent Health Inc saw a sharp steep in short interest on 2025-10-31 dropping by -1.75 million shares to 17.06 million. Data from Yahoo Finance shows that the short interest on 2025-09-30 was 18.81 million shares. A decline of -10.26% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 7.17 of the overall float, the days-to-cover ratio (short ratio) decline to 7.17.
Which companies own the most shares of Evolent Health Inc (EVH)?
In terms of Evolent Health Inc share price expectations, FactSet research, analysts set an average price target of 28 in the next 12 months, up nearly 600.0% from the previous closing price of $4.0. Analysts anticipate Evolent Health Inc stock to reach 51 by 2025, with the lowest price target being 14. In spite of this, 5 analysts ranked Evolent Health Inc stock as Buy at the end of 2025. On November 08, 2024, Stephens assigned a price target of “an Equal-weight” to the stock and downgraded coverage with a $16.
